Investing

Rocket Pharmaceuticals : RCKT

RCKT

Stock Data

$3.56

$0.08 (2.30%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Rocket Pharmaceuticals Inc is a pioneering biotechnology firm dedicated to developing gene therapies for rare and severe diseases. With a focus on late-stage research, the company is advancing treatments for conditions like fanconi anemia, leukocyte adhesion deficiency-I, and pyruvate kinase deficiency, all of which impact blood cell production or function. Additionally, Rocket Pharmaceuticals is working on gene therapies for Danon disease and various cardiac disorders, leveraging partnerships with research institutions and leveraging cutting-edge technology to address unmet medical needs. Founded in 1999, Rocket Pharmaceuticals is headquartered in Cranbury, New Jersey.

All Rocket Pharmaceuticals Articles

2 Articles

Chris Lange | Nov 8, 2022 at 12:10 PM EST

Will Election Day Prove Bullish? Analysts Upgrade or Downgrade Block, Lyft and More

Tuesday’s additional top analyst upgrades and downgrades were on Ballard Power Systems, Block, Dave & Buster’s Entertainment, DigitalOcean, Lyft, Six…

Paul Ausick | Feb 18, 2021 at 2:21 PM EST

Seagate, Micron, Invitae and More Thursday Afternoon Analyst Calls

Here's the Thursday afternoon edition of analysts' upgrades, downgrades and price target changes on several popular stocks.